Watson Pharmaceuticals Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Corona CA United States (1983)
Status: Acquired by Actavis (2012) → now AbbVie (2019)

Organization Overview

First Clinical Trial
2002
NCT00224094
First Marketed Drug
1983
reserpine (serpasil)
First NDA Approval
2008
silodosin (rapaflo)
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Qingdao Co-orient Watson Biotechnology group co. LTD | Watson Laboratories | Watson Laboratories, Inc. | WATSON LABS | WATSON LABS FLORIDA | WATSON LABS INC | WATSON LPHARMACEUTICAL | Watson Pharmaceuticals | Watson Pharmaceuticals, Inc. | WATSON PHARMS INC | WATSON PHARMS TEVA